Derlemeler
1) Cansev M (2006)
Uridine and cytidine in the brain: Their transport and utilization. Brain Res. Rev., 52: 389-397.
Link
2) Cansev M (2007)
Involvement of uridine-nucleotide-stimulated P2Y receptors in neuronal growth and function. Centr. Nerv. Syst. Agents Med. Chem., 7: 223-229. doi: 10.2174/187152407783220814.
Link
3) Cansev M, Wurtman RJ, Sakamoto T, Ulus IH (2008)
Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement., 4: S153-S168. doi: 10.1016/j.jalz.2007.10.005.
Link
4) Wurtman RJ, Cansev M, Ulus IH, Sakamoto T (2009)
Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr., 29: 59-87. doi: 10.1146/annurev-nutr-080508-141059.
Link
5) Wurtman RJ, Cansev M, Ulus IH (2009)
Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. J. Nutr. Health Aging, 13: 189-197.
Link
6) Wurtman RJ, Cansev M, Sakamoto T, Ulus IH (2010)
Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. Nutr. Rev., 68(Suppl. 2): S88-S101. doi: 10.1111/j.1753-4887.2010.00344.x.
Link
7) Ulus IH, Cansev M (2010)
Roles of choline on central and peripheral cholinergic neurones and cholinergic neurotransmission. Acibadem University Journal of Health Sciences, 1(2): 68-80.
Link
8) Mi W, van Wijk N, Cansev M, Sijben JWC, Kamphuis PJGH (2013)
Nutritional approaches in the risk reduction and management of Alzheimer’s disease. Nutrition, 29(9):1080-1089. doi: 10.1016/j.nut.2013.01.024.
Link
9) Cansev M (2016)
Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors. Neuromolecular Med, 18(3): 426-440. doi: 10.1007/s12017-016-8414-x.
Link